AMR vs FSM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Despite a strong Piotroski F-Score of 7/9 indicating solid financial health on certain fundamentals, AMR faces significant challenges including negative profitability metrics, declining revenue, and a lack of Altman Z-Score to confirm financial stability. The stock trades at a high forward P/E of 10.82 amid negative earnings trends and collapsing year-over-year EPS growth of -244.8%, while insiders have shown bearish sentiment with $3.81M in net sales. Analysts recommend 'buy' but with limited consensus (only 2 analysts), and technical trend is deeply bearish at 10/100. The extreme 5-year price surge of +1710.4% appears disconnected from deteriorating fundamentals, raising sustainability concerns.
Fortuna Mining Corp. presents a compelling value opportunity, trading almost exactly at its Graham Number ($10.24) and significantly below its intrinsic value of $25.07. While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, this is offset by an exceptionally clean balance sheet with a Debt/Equity ratio of 0.12 and a strong Current Ratio of 2.98. Despite a bearish technical trend and a poor track record of meeting earnings estimates, the company's massive YoY earnings growth and low forward P/E (5.75) suggest significant upside potential.
Compare Another Pair
Related Comparisons
AMR vs FSM: Head-to-Head Comparison
This page compares Alpha Metallurgical Resources, Inc. (AMR) and Fortuna Mining Corp. (FSM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.